✦ LIBER ✦

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine

✍ Scribed by Syoji Kuzuhara; Hideki Nakamura; Kenshi Hayashida; Junko Obata; Motoharu Abe; Kengo Sonoda; Kiyoto Nishiyama; Keishin Sugawara; Kengo Takeda; Tomitaka Honda; Hajime Matsui; Takamichi Shigaki; Yoichiro Kino; Hiroshi Mizokami; Masahiko Tanaka; Kyosuke Mizuno; Kohji Ueda

Book ID: 117431802
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 105 KB
Volume: 21
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(03)00506-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a Vero-cell

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

✍ E Tauber; H Kollaritsch; M Korinek; P Rendi-Wagner; B Jilma; C Firbas; S Schranz 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 156 KB

Long-term immunogenicity of the new Vero

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51: Six and 12 month results of a multicenter follow-up phase 3 study

✍ E. Schuller; B. Jilma; V. Voicu; G. Golor; H. Kollaritsch; A. Kaltenböck; C. Kla 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Safety and immunogenicity of a freeze-dr

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

✍ Kenji Okada; Toshiaki Iwasa; Junko Namazue; Masateru Akechi; Shigeharu Ueda 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial

✍ N. Groth; E. Montomoli; C. Gentile; I. Manini; R. Bugarini; A. Podda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial

✍ Gerald Aichinger; Hartmut J. Ehrlich; John G. Aaskov; Sandor Fritsch; Christiane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Clinical Evaluation of Dendritic Cell Va

Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial

✍ Yamanaka, R. 📂 Article 📅 2005 🏛 American Association for Cancer Research 🌐 English ⚖ 689 KB